303 related articles for article (PubMed ID: 36190732)
1. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract][Full Text] [Related]
2. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Nomair AM; Kandil LS; Nomeir HM; Kandil NS
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
[TBL] [Abstract][Full Text] [Related]
3. The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.
Patsenker E; Thangapandi VR; Knittelfelder O; Palladini A; Hefti M; Beil-Wagner J; Rogler G; Buch T; Shevchenko A; Hampe J; Stickel F
J Nutr Biochem; 2022 Oct; 108():109081. PubMed ID: 35691594
[TBL] [Abstract][Full Text] [Related]
4. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.
Burza MA; Pirazzi C; Maglio C; Sjöholm K; Mancina RM; Svensson PA; Jacobson P; Adiels M; Baroni MG; Borén J; Ginanni Corradini S; Montalcini T; Sjöström L; Carlsson LM; Romeo S
Dig Liver Dis; 2012 Dec; 44(12):1037-41. PubMed ID: 22704398
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
[TBL] [Abstract][Full Text] [Related]
6. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.
Burza MA; Molinaro A; Attilia ML; Rotondo C; Attilia F; Ceccanti M; Ferri F; Maldarelli F; Maffongelli A; De Santis A; Attili AF; Romeo S; Ginanni Corradini S
Liver Int; 2014 Apr; 34(4):514-20. PubMed ID: 24102786
[TBL] [Abstract][Full Text] [Related]
7. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U
PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248
[TBL] [Abstract][Full Text] [Related]
8. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
[TBL] [Abstract][Full Text] [Related]
9. PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
Friedrich K; Wannhoff A; Kattner S; Brune M; Hov JR; Weiss KH; Antoni C; Dollinger M; Neumann-Haefelin C; Seufferlein T; Schemmer P; Schirmacher P; Stremmel W; Gotthardt DN
J Gastroenterol Hepatol; 2014; 29(7):1477-84. PubMed ID: 25273282
[TBL] [Abstract][Full Text] [Related]
10. Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
Caon E; Martins M; Hodgetts H; Blanken L; Vilia MG; Levi A; Thanapirom K; Al-Akkad W; Abu-Hanna J; Baselli G; Hall AR; Luong TV; Taanman JW; Vacca M; Valenti L; Romeo S; Mazza G; Pinzani M; Rombouts K
J Hepatol; 2024 Jun; 80(6):941-956. PubMed ID: 38365182
[TBL] [Abstract][Full Text] [Related]
11. PNPLA3, obesity and heavy alcohol use in cirrhosis patients may exert a synergistic increase hepatocellular carcinoma risk.
Thrift AP; Kanwal F; Lim H; Duong H; Liu Y; Singal AG; Khaderi S; Asrani SK; Amos CI; El-Serag HB
Clin Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38729396
[TBL] [Abstract][Full Text] [Related]
12. Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
Tsai MC; Yang SS; Lin CC; Wang WL; Hsu YC; Chen YS; Hu JT; Lin JY; Yu ML; Lin CW
JAMA Netw Open; 2022 Jul; 5(7):e2223511. PubMed ID: 35877121
[TBL] [Abstract][Full Text] [Related]
13. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers.
Stickel F; Lutz P; Buch S; Nischalke HD; Silva I; Rausch V; Fischer J; Weiss KH; Gotthardt D; Rosendahl J; Marot A; Elamly M; Krawczyk M; Casper M; Lammert F; Buckley TWM; McQuillin A; Spengler U; Eyer F; Vogel A; Marhenke S; von Felden J; Wege H; Sharma R; Atkinson S; Franke A; Nehring S; Moser V; Schafmayer C; Spahr L; Lackner C; Stauber RE; Canbay A; Link A; Valenti L; Grove JI; Aithal GP; Marquardt JU; Fateen W; Zopf S; Dufour JF; Trebicka J; Datz C; Deltenre P; Mueller S; Berg T; Hampe J; Morgan MY
Hepatology; 2020 Jul; 72(1):88-102. PubMed ID: 31630428
[TBL] [Abstract][Full Text] [Related]
14. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL
PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878
[TBL] [Abstract][Full Text] [Related]
15. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
[TBL] [Abstract][Full Text] [Related]
16. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
[TBL] [Abstract][Full Text] [Related]
17. Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
Ohta A; Ogawa E; Murata M; Matsumoto Y; Yamasaki S; Ikezaki H; Furusyo N
J Med Virol; 2022 Oct; 94(10):5007-5014. PubMed ID: 35652276
[TBL] [Abstract][Full Text] [Related]
18. Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population.
Gellert-Kristensen H; Richardson TG; Davey Smith G; Nordestgaard BG; Tybjaerg-Hansen A; Stender S
Hepatology; 2020 Sep; 72(3):845-856. PubMed ID: 32190914
[TBL] [Abstract][Full Text] [Related]
19. Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.
Unalp-Arida A; Ruhl CE
Hepatology; 2020 Mar; 71(3):820-834. PubMed ID: 31705824
[TBL] [Abstract][Full Text] [Related]
20. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
